COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)
- PMID: 33781551
- PMCID: PMC7951944
- DOI: 10.1016/j.bulcan.2021.02.004
COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)
Abstract
Since the emergence of the SARS-CoV-2 infection, many recommendations have been made. However, the very specific nature of acute lymphoblastic leukemias and their treatment in children and adolescents led the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE) to propose more specific recommendations. Here is the second version of these recommendations updated according to the evolution of knowledge on COVID19.
Keywords: Acute lymphoblastic leukemia; Adolescents; COVID 19; Children; SARS-CoV-2.
Copyright © 2021 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.
References
-
- Baruchel A., Bertrand Y., Boissel N., Brethon B., Ducassou S., Gandemer V. COVID-19 and acute lymphoblastic leukemias of children and adolescents: first recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE) Bull Cancer. 2020;107(6):629–632. - PMC - PubMed
-
- Bouffet E., Challinor J., Sullivan M., Biondi A., Rodriguez-Galindo C., Pritchard-Jones K. Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences. Pediatr Blood Cancer. 2020;67(7):e28327. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous